Who Holds Armata Pharmaceuticals, Inc. (ARMP)? 53 Institutional Holders, Q2 2026
Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 53 holders, $32 million in total.
Largest holders
The 53 largest by value. Change in shares against Q1 2026.
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| Madison Asset Management, LLC | 2,107,175 | $14 million | 0% | 13F |
| BlackRock, Inc. | 559,986 | $4 million | +761% | 13F |
| VANGUARD CAPITAL MANAGEMENT LLC | 487,968 | $3 million | +33% | 13F |
| MILLENNIUM MANAGEMENT LLC | 470,500 | $3 million | +82% | 13F |
| GEODE CAPITAL MANAGEMENT, LLC | 270,550 | $2 million | +136% | 13F |
| Dauntless Investment Group, LLC | 203,891 | $1 million | +125% | 13F |
| STATE STREET CORP | 129,600 | $839,808 | +155% | 13F |
| NORTHERN TRUST CORP | 89,791 | $581,845 | +264% | 13F |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 81,354 | $527,174 | New | 13F |
| EDGEWOOD MANAGEMENT LLC | 80,000 | $518,400 | -20% | 13F |
| VANGUARD FIDUCIARY TRUST CO | 79,495 | $515,128 | +17% | 13F |
| Grey Ledge Advisors, LLC | 50,000 | $324,000 | +67% | 13F |
| RENAISSANCE TECHNOLOGIES LLC | 48,318 | $313,101 | +26% | 13F |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 44,682 | $289,539 | +0% | 13F |
| SeaCrest Wealth Management, LLC | 41,524 | $269,076 | +0% | 13F |
| Bank of New York Mellon Corp | 29,749 | $192,774 | New | 13F |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 28,857 | $186,993 | New | 13F |
| Hudson Bay Capital Management LP | 17,584 | $113,944 | +0% | 13F |
| Nuveen, LLC | 15,905 | $103,064 | New | 13F |
| NEW YORK STATE COMMON RETIREMENT FUND | 15,400 | $99,792 | New | 13F |
| UBS Group AG | 13,697 | $88,757 | +215% | 13F |
| CAPTRUST FINANCIAL ADVISORS | 13,140 | $85,147 | +0% | 13F |
| DEUTSCHE BANK AG\ | 11,966 | $77,540 | New | 13F |
| BANK OF AMERICA CORP /DE/ | 11,305 | $73,256 | -3% | 13F |
| XTX Topco Ltd | 10,826 | $70,152 | New | 13F |
| WELLS FARGO & COMPANY/MN | 10,819 | $70,104 | +1081800% | 13F |
| RHUMBLINE ADVISERS | 8,453 | $54,770 | New | 13F |
| Police & Firemen's Retirement System of New Jersey | 6,095 | $39,496 | New | 13F |
| CITIGROUP INC | 5,603 | $36,307 | +9% | 13F |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 5,461 | $35,387 | New | 13F |
| JPMORGAN CHASE & CO | 4,916 | $31,757 | New | 13F |
| MORGAN STANLEY | 4,583 | $29,697 | +36% | 13F |
| Vanguard Global Advisers, LLC | 3,964 | $25,687 | +0% | 13F |
| BNP PARIBAS FINANCIAL MARKETS | 3,038 | $19,686 | New | 13F |
| BARCLAYS PLC | 2,984 | $19,337 | +1838% | 13F |
| STRS OHIO | 2,300 | $14,904 | New | 13F |
| Tower Research Capital LLC (TRC) | 2,034 | $13,180 | +634% | 13F |
| Cornerstone National Bank & Trust Co | 1,428 | $8,397 | +0% | 13F |
| Legal & General Group Plc | 1,161 | $7,523 | New | 13F |
| Ameritas Investment Partners, Inc. | 1,076 | $6,972 | New | 13F |
| Measured Wealth Private Client Group, LLC | 1,000 | $6,480 | +0% | 13F |
| Russell Investments Group, Ltd. | 969 | $6,279 | New | 13F |
| SIMPLEX TRADING, LLC | 794 | $5,145 | New | 13F |
| Trifecta Capital Advisors, LLC | 714 | $4,627 | +0% | 13F |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 571 | $3,700 | +0% | 13F |
| ROYAL BANK OF CANADA | 497 | $3,000 | New | 13F |
| FMR LLC | 364 | $2,360 | +1555% | 13F |
| Silver Grove Financial Group, Inc. | 200 | $1,296 | +0% | 13F |
| SALEM INVESTMENT COUNSELORS INC | 100 | $648 | +0% | 13F |
| Geneos Wealth Management Inc. | 92 | $596 | +0% | 13F |
| WHITTIER TRUST CO | 100 | $544 | +0% | 13F |
| Sterling Capital Management LLC | 42 | $272 | New | 13F |
| SBI Securities Co., Ltd. | 3 | $19 | +0% | 13F |
Questions and answers
- How many institutions hold Armata Pharmaceuticals, Inc.?
- 53 managers reported Armata Pharmaceuticals, Inc. on Form 13F for the quarter ended 30 June 2026, against 45 the quarter before.
- Who is the largest institutional holder of Armata Pharmaceuticals, Inc.?
- Madison Asset Management, LLC, with 2,107,175 shares worth $14 million on its 13F for Q2 2026.
- How many institutions bought or sold out of Armata Pharmaceuticals, Inc. in Q2 2026?
- 19 managers reported a new position and 11 reported none after holding it the quarter before.
Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds Armata Pharmaceuticals, Inc., Q2 2026", https://app.tamarly.ai/holders/armata-pharmaceuticals, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.